Speaker illustration

Professor Srihari Naidu

New York (United States of America)

Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial

Event: Heart Failure 2021 Online Congress

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease

Thumbnail

This platform is supported by

logo Novo Nordisk